Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single/Multiple Ascending Dose Phase 1 Study of the Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Human Volunteers

NCT04103034 is registered in ClinicalTrials.gov with Band Therapeutics as lead sponsor.

NCT NCT04103034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04103034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single/Multiple Ascending Dose Phase 1 Study of the Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Human Volunteers
Lead sponsor
Band Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
October 7, 2019
Completion date
September 14, 2020
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular stroke, intracranial arteriosclerosis, large-artery atherosclerosis (embolus/thrombosis)